Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal decongestant plus corticosteroid versus double-dose intranasal corticosteroid in moderate to severe allergic rhinitis
TCTR20250911002Phase 4Recruiting
- Sponsor
- Bannawat Tantikun
- Start
- May 2025
- Countries
- 1
01
Overview
Phase 4, randomised trial in allergic rhinitis (AR) (2 arms), sponsored by Bannawat Tantikun. Started May 2025; status: recruiting.
02
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on TCTR20250911002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250911002.